Barclays PLC Aurinia Pharmaceuticals Inc. Transaction History

Barclays PLC

$357 Billion
Q4 2024

A detailed history of Barclays PLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Barclays PLC holds 243,948 shares of AUPH stock, worth $1.96 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

243,948

Previous 219,331 11.22%

Holding current value

$1.96 Million

Previous $1.61 Million 36.28%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$6.75 - $10.44 $166,164 - $257,001	24,617 Added 11.22%	243,948 $2.19 Million
Q3 2024 Nov 15, 2024	BUY	$5.32 - $7.33 $761,143 - $1.05 Million	143,072 Added 187.61%	219,331 $1.61 Million
Q2 2024 Aug 14, 2024	SELL	$4.81 - $5.78 $463,996 - $557,567	-96,465 Reduced 55.85%	76,259 $435,000
Q1 2024 May 15, 2024	SELL	$4.93 - $9.31 $225,414 - $425,681	-45,723 Reduced 20.93%	172,724 $865,000
Q4 2023 Feb 15, 2024	BUY	$7.13 - $9.49 $646,826 - $860,923	90,719 Added 71.03%	218,447 $1.96 Million
Q3 2023 Nov 07, 2023	BUY	$7.77 - $12.27 $602,905 - $952,078	77,594 Added 154.77%	127,728 $992,000
Q2 2023 Aug 03, 2023	SELL	$8.96 - $11.69 $159,658 - $208,304	-17,819 Reduced 26.22%	50,134 $485,000
Q1 2023 May 04, 2023	BUY	$5.94 - $11.27 $19,186 - $36,402	3,230 Added 4.99%	67,953 $745,000
Q4 2022 Feb 13, 2023	SELL	$4.11 - $8.14 $2.43 Million - $4.82 Million	-592,079 Reduced 90.15%	64,723 $279,000
Q3 2022 Nov 03, 2022	SELL	$6.66 - $12.39 $2.56 Million - $4.76 Million	-384,252 Reduced 36.91%	656,802 $4.94 Million
Q2 2022 Aug 12, 2022	BUY	$8.95 - $12.8 $5.35 Million - $7.64 Million	597,256 Added 134.58%	1,041,054 $10.5 Million
Q1 2022 May 16, 2022	SELL	$10.05 - $22.48 $908,610 - $2.03 Million	-90,409 Reduced 16.92%	443,798 $5.49 Million
Q4 2021 Feb 14, 2022	SELL	$17.78 - $33.08 $1.08 Million - $2 Million	-60,599 Reduced 10.19%	534,207 $12.2 Million
Q3 2021 Nov 09, 2021	BUY	$10.93 - $23.55 $4.42 Million - $9.51 Million	403,950 Added 211.65%	594,806 $13.2 Million
Q2 2021 Aug 13, 2021	SELL	$10.0 - $14.52 $2.24 Million - $3.26 Million	-224,404 Reduced 54.04%	190,856 $2.47 Million
Q1 2021 May 13, 2021	BUY	$12.3 - $18.73 $3.15 Million - $4.8 Million	256,236 Added 161.13%	415,260 $5.39 Million
Q4 2020 Feb 11, 2021	SELL	$12.94 - $16.05 $815,220 - $1.01 Million	-63,000 Reduced 28.38%	159,024 $2.2 Million
Q3 2020 Nov 12, 2020	BUY	$13.19 - $16.66 $1.9 Million - $2.4 Million	144,338 Added 185.8%	222,024 $3.27 Million
Q1 2020 May 13, 2020	SELL	$11.34 - $21.46 $302,653 - $572,745	-26,689 Reduced 25.57%	77,686 $1.13 Million
Q4 2019 Feb 10, 2020	BUY	$3.88 - $21.42 $132,366 - $730,743	34,115 Added 48.56%	104,375 $2.12 Million
Q3 2019 Nov 14, 2019	BUY	$5.34 - $6.59 $371,626 - $458,617	69,593 Added 10433.73%	70,260 $376,000
Q2 2019 Aug 14, 2019	SELL	$6.05 - $6.75 $1,954 - $2,180	-323 Reduced 32.63%	667 $4,000
Q1 2019 May 15, 2019	BUY	$6.06 - $7.64 $5,817 - $7,334	960 Added 3200.0%	990 $6,000
Q2 2018 Aug 14, 2018	SELL	$5.06 - $6.36 $5,009 - $6,296	-990 Reduced 97.06%	30 $0
Q1 2018 May 15, 2018	BUY	$4.85 - $5.99 $4,947 - $6,109	1,020 New	1,020 $5,000
Q4 2017 Feb 14, 2018	SELL	$4.53 - $7.09 $86,523 - $135,419	-19,100 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$5.71 - $6.9 $109,061 - $131,790	19,100	19,100 $120,000

Others Institutions Holding AUPH

# of Institutions

227

Shares Held

58.9M

Call Options Held

949K

Put Options Held

1.51M

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.14B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account